Gene targeting in mouse embryonic stem cells with an adenoviral vector

scientific article

Gene targeting in mouse embryonic stem cells with an adenoviral vector is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02255777
P698PubMed publication ID8525428

P2093author name stringBradley A
Caskey CT
Graham FL
Mitani K
Hasty P
Wakamiya M
P2860cites workThe Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brainQ28586297
Characteristics of a human cell line transformed by DNA from human adenovirus type 5Q29547863
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in miceQ29547898
The spectrum of cystic fibrosis mutationsQ35150488
Correction of a deletion mutant by gene targeting with an adenovirus vectorQ36660845
The role and fate of DNA ends for homologous recombination in embryonic stem cellsQ40654945
Efficiency of insertion versus replacement vector targeting varies at different chromosomal lociQ43182345
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectAdenoviridaeQ193447
gene targetingQ211083
P304page(s)221-231
P577publication date1995-07-01
P1433published inSomatic Cell and Molecular GeneticsQ7559232
P1476titleGene targeting in mouse embryonic stem cells with an adenoviral vector
P478volume21

Reverse relations

cites work (P2860)
Q24813890A trial of somatic gene targeting in vivo with an adenovirus vector
Q39604468Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer
Q34016088Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors
Q34585554Current strategies and future directions for eluding adenoviral vector immunity
Q36149196Gene targeting with viral vectors
Q36789527Gene therapy for type I glycogen storage diseases
Q38170509Genetic correction using engineered nucleases for gene therapy applications
Q36828787Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice
Q34070145Herpes simplex virus type 1-based amplicon vector systems
Q41526863Human Adenovirus Vectors for Gene Transfer into Mammalian Cells
Q41480639Human gene targeting by viral vectors
Q44406262Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells
Q40746282Rearrangements in adenoviral genomes mediated by inverted repeats
Q50657873Targeted genome modifications using integrase-deficient lentiviral vectors.
Q35847178Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances

Search more.